Shenzhen Wenxi Technology Co., Ltd. – Trademark Portfolio
Entity Type: 16
Shenzhen Wenxi Technology Co., Ltd. owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as VUCVY, WEXFFU, KAASAGE, and SUPSLEEP. Of these, 4 are registered. The portfolio spans 4 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 8 (Hand Tools). Headquartered in Shenzhen, Guangdong.
7H13, Block 4,
SEG Science and Technology Park,
Shenzhen, Guangdong 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Wenxi Technology Co., Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shenzhen Wenxi Technology Co., Ltd. have?
Shenzhen Wenxi Technology Co., Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Shenzhen Wenxi Technology Co., Ltd. file in?
Shenzhen Wenxi Technology Co., Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 8 (Hand Tools), Class 21 (Housewares), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Shenzhen Wenxi Technology Co., Ltd.'s most well-known trademarks?
Shenzhen Wenxi Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as VUCVY, WEXFFU, KAASAGE, and SUPSLEEP. These are among 4 currently registered trademarks in the portfolio.
What is Shenzhen Wenxi Technology Co., Ltd.'s trademark registration success rate?
Shenzhen Wenxi Technology Co., Ltd. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.